The families of two Pret a Manger customers who died after experiencing severe allergic reactions have welcomed a report from a senior coroner suggesting hospitals should be obliged to report fatal and near-fatal anaphylaxis.
Maria Voisin, the senior coroner for Avon, said a robust system of capturing and recording serious cases of anaphylaxis could provide an early warning of the risk posed to allergic individual byproducts with an undeclared allergen content.
She said the system could involve mandatory reporting by hospitals to local health protection officials of anaphylaxis similar to the current system for notifiable diseases.
Allergy Therapeutics plc (LON:AGY) is a market-leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.